Report #2885534

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

female received Flublok, at which time individual was under the age of 18 with no reported adverse event; Initial information received on 05-Feb-2026 regarding an unsolicited valid non-serious case received from a consumer/Non-Healthcare Professional. This case involves an unknown age female patient who received INFLUENZA TRIVALENT RECOMBINANT VACCINE [FLUBLOK], at which time individual was under the age of 18 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received INFLUENZA TRIVALENT RECOMBINANT VACCINE Solution for injection (strength, dose, batch and expiry date unknown) via unknown route in unknown administration site for prophylactic vaccination (Immunization) at which time individual was under the age of 18 with no reported adverse event (product administered to patient of inappropriate age) (same day latency). Information on batch number and expiry date corresponding to the one at time of event occurrence was requested. Action taken-not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.